LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
 48.65 84.90 128 5328 0.0240 0.0712
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 48.65 84.90 1418 5328 0.2661 0.6023
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 50.36 84.90 1640 5651 0.2902 0.6305
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 50.36 84.90 1710 5651 0.3026 0.6418
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 50.36 84.90 144 5651 0.0255 0.0912
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 50.36 84.90 1421 5651 0.2515 0.5924
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 52.06 84.90 1636 5990 0.2731 0.6190
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 52.06 84.90 1702 5990 0.2841 0.6294
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 52.06 84.90 156 5990 0.0260 0.1042
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 52.06 84.90 1408 5990 0.2350 0.5799
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 53.77 84.90 1659 6252 0.2653 0.6148
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 53.77 84.90 1720 6252 0.2751 0.6243
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 53.77 84.90 172 6252 0.0275 0.1206
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 53.77 84.90 1458 6252 0.2332 0.5816
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 55.48 84.90 1751 6567 0.2666 0.6200
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 55.48 84.90 1811 6567 0.2757 0.6287
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 55.48 84.90 155 6567 0.0236 0.1007
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 55.48 84.90 1612 6567 0.2454 0.5988
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 57.18 84.90 1801 6963 0.2586 0.6168
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 57.18 84.90 1860 6963 0.2671 0.6250
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 57.18 84.90 161 6963 0.0231 0.1059
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 57.18 84.90 1600 6963 0.2298 0.5870
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 58.88 84.90 1901 7291 0.2607 0.6224
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 58.88 84.90 1969 7291 0.2700 0.6313
MN20160318_Q02
G10
MCF 10A-H2B-mCherry Trametinib
0.01
 58.88 84.90 170 7291 0.0233 0.1141
MN20160318_Q02
N22